Shopping Cart 0
Cart Subtotal
USD 0

PharmAthene Inc (PIP)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

PharmAthene Inc (PharmAthene) is a pharmaceutical company that develops and commercializes medical counter measures to biological and chemical weapons. The company's products include recombinant protective antigen anthrax vaccine, human monoclonal antibody antitoxin and recombinant BChE bioscavenger. Its products are used for treatment of anthrax, and nerve agent poisoning. PharmAthene serves in markets of biodefense, US civilian, military, and non-US markets. The company collaborates with various pharma and research companies across the world. It markets its products through its distributors across the world. PharmaAthene is headquartered in Annapolis, Maryland, the US.

PharmAthene Inc (PIP)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

PharmAthene Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

PharmAthene Inc, Pharmaceuticals & Healthcare, Deal Details 10

Merger 10

Altimmune Merges with PharmAthene in Reverse Merger Transaction 10

Licensing Agreements 11

Immunovaccine Enters into Licensing Agreement with PharmAthene 11

PharmAthene Enters Into Licensing Agreement With Percivia For PER.C6 Cell Line 12

Equity Offering 13

PharmAthene to Raise Additional USD30 Million in Public Offering of Shares 13

PharmAthene Completes Registered Direct Offering Of US$6.5 Million 14

PharmAthene Inc-Key Competitors 16

Key Employees 17

Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 19

Financial Announcements 19

May 03, 2017: PharmAthene Reports First Quarter 2017 Financial and Operational Results 19

Mar 14, 2017: PharmAthene Reports Year-End 2016 Financial and Operational Results 20

Nov 04, 2016: PharmAthene Reports Third Quarter 2016 Financial and Operational Results 21

Aug 04, 2016: PharmAthene Reports Second Quarter 2016 Financial and Operational Results 22

May 09, 2016: PharmAthene Reports First Quarter 2016 Financial and Operational Results 23

Mar 11, 2016: PharmAthene Reports Year-End 2015 Financial and Operational Results; Provides Update on Litigation with SIGA 24

Corporate Communications 25

Jul 08, 2016: PharmAthene Receives $20 Million Payment from SIGA to Extend Payment Deadline 25

Legal and Regulatory 26

Nov 16, 2016: PharmAthene Receives Final Payment from SIGA of $83.9 Million 26

Apr 13, 2016: PharmAthene Reports Court Approval of SIGA Reorganization Plan to Exit from Bankruptcy 27

Other Significant Developments 28

Sep 16, 2016: PharmAthene Announces Receipt of Payments from SIGA 28

Appendix 29

Methodology 29

About GlobalData 29

Contact Us 29

Disclaimer 29


List Of Figure

List of Figures

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8


List Of Table

List of Tables

PharmAthene Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

PharmAthene Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

PharmAthene Inc, Deals By Therapy Area, 2011 to YTD 2017 8

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Altimmune Merges with PharmAthene in Reverse Merger Transaction 10

Immunovaccine Enters into Licensing Agreement with PharmAthene 11

PharmAthene Enters Into Licensing Agreement With Percivia For PER.C6 Cell Line 12

PharmAthene to Raise Additional USD30 Million in Public Offering of Shares 13

PharmAthene Completes Registered Direct Offering Of US$6.5 Million 14

PharmAthene Inc, Key Competitors 16

PharmAthene Inc, Key Employees 17

PharmAthene Inc, Subsidiaries 18

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

PharmAthene Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

PharmAthene Inc (PharmAthene) is a pharmaceutical company that develops and commercializes medical counter measures to biological and chemical weapons. The company's products include recombinant protective antigen anthrax vaccine, human monoclonal antibody antitoxin and recombinant BChE bioscavenger. Its products are used for treatment of anthrax, and nerve agent poisoning. PharmAthene serves in markets of biodefense, US civilian, military, and non-US markets. The company collaborates with various pharma and research companies across the world. It markets its products through its distributors across the world. PharmaAthene is headquartered in Annapolis, Maryland, the US.

PharmAthene Inc (PIP)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

PharmAthene Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

PharmAthene Inc, Pharmaceuticals & Healthcare, Deal Details 10

Merger 10

Altimmune Merges with PharmAthene in Reverse Merger Transaction 10

Licensing Agreements 11

Immunovaccine Enters into Licensing Agreement with PharmAthene 11

PharmAthene Enters Into Licensing Agreement With Percivia For PER.C6 Cell Line 12

Equity Offering 13

PharmAthene to Raise Additional USD30 Million in Public Offering of Shares 13

PharmAthene Completes Registered Direct Offering Of US$6.5 Million 14

PharmAthene Inc-Key Competitors 16

Key Employees 17

Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 19

Financial Announcements 19

May 03, 2017: PharmAthene Reports First Quarter 2017 Financial and Operational Results 19

Mar 14, 2017: PharmAthene Reports Year-End 2016 Financial and Operational Results 20

Nov 04, 2016: PharmAthene Reports Third Quarter 2016 Financial and Operational Results 21

Aug 04, 2016: PharmAthene Reports Second Quarter 2016 Financial and Operational Results 22

May 09, 2016: PharmAthene Reports First Quarter 2016 Financial and Operational Results 23

Mar 11, 2016: PharmAthene Reports Year-End 2015 Financial and Operational Results; Provides Update on Litigation with SIGA 24

Corporate Communications 25

Jul 08, 2016: PharmAthene Receives $20 Million Payment from SIGA to Extend Payment Deadline 25

Legal and Regulatory 26

Nov 16, 2016: PharmAthene Receives Final Payment from SIGA of $83.9 Million 26

Apr 13, 2016: PharmAthene Reports Court Approval of SIGA Reorganization Plan to Exit from Bankruptcy 27

Other Significant Developments 28

Sep 16, 2016: PharmAthene Announces Receipt of Payments from SIGA 28

Appendix 29

Methodology 29

About GlobalData 29

Contact Us 29

Disclaimer 29


List Of Figure

List of Figures

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8


List Of Table

List of Tables

PharmAthene Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

PharmAthene Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

PharmAthene Inc, Deals By Therapy Area, 2011 to YTD 2017 8

PharmAthene Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Altimmune Merges with PharmAthene in Reverse Merger Transaction 10

Immunovaccine Enters into Licensing Agreement with PharmAthene 11

PharmAthene Enters Into Licensing Agreement With Percivia For PER.C6 Cell Line 12

PharmAthene to Raise Additional USD30 Million in Public Offering of Shares 13

PharmAthene Completes Registered Direct Offering Of US$6.5 Million 14

PharmAthene Inc, Key Competitors 16

PharmAthene Inc, Key Employees 17

PharmAthene Inc, Subsidiaries 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

PharmAthene Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.